- Presentations
- 4
- Markets
- 1
Invega is a brand of Paliperidone marketed by Janssen Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Paliperidone
- Brand owner
- Janssen Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 1.5 mg extended-release tablet, 3 mg extended-release tablet, 6 mg extended-release tablet, 9 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Invega 1.5 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega 3 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega 6 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega 9 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Invega
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.